Henry

Henry Meds is a prominent telehealth company that specializes in providing accessible and affordable subscription-based healthcare for chronic conditions, with a primary focus on weight management and endocrine health. Founded in 2022, the company has rapidly grown by offering personalized treatment plans that include compounded medications such as semaglutide and tirzepatide for weight loss. Their business model bypasses traditional insurance requirements, connecting patients directly with licensed healthcare providers and delivering medications to their homes. In addition to weight management, Henry Meds provides services for hormone replacement therapy, insomnia, and other metabolic health concerns.